LUCID CAPITAL MARKETS Initiates Coverage On Adagio Medical Holdings with Buy Rating, Announces Price Target of $3
Benzinga Newsdesk 5 months ago
NewsPrice TargetInitiationAnalyst Ratings
LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Adagio Medical Holdings (NASDAQ:ADGM) with a Buy rating and announces Price Target of $3.
LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Adagio Medical Holdings (NASDAQ:ADGM) with a Buy rating and announces Price Target of $3.